$WW

WW INTERNATIONAL, INC. (WW): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

WW INTERNATIONAL, INC. (WW) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Exhibit 99.1 Weight Watchers Appoints Stephen Bye as Chief Executive Officer Seasoned CEO Brings Track Record of Business Transformation, Consumer Subscription Growth and Significant Value Creation NEW YORK, September 9, 2026 — WW International, Inc. (NASDAQ: WW) (“Weight Watcher

Original reporting
Published Sep 9, 2026, 12:01 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 9, 2026, 12:02 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$WW
Neutral
medium confidence
Mentioned
$WW
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$WWNeutralMed
01

Why it matters

The appointment could reshape the company's strategic direction, emphasizing technology and subscription growth.

02

Market read

Executive change is a primary corporate event that may affect WW's stock trajectory.

03

What to watch

Potential integration challenges with existing clinical services and GLP‑1 medication partnerships.

Relevance 6/10Novelty 7/10Timing: announcement today

Background

SEC Form 8‑K filing disclosed the leadership transition at Weight Watchers.

Company-level read

Ticker impact

$WWNeutralMedium confidence
Context

Weight Watchers (NASDAQ: WW) announced the appointment of Stephen Bye as President, CEO and board member, effective this fall.

Expected impact

Potential modest upside as investors assess execution of the new leadership plan.

Evidence & confidence

Executive changes are material but the impact depends on execution; no immediate financial metrics were disclosed.

Market effects

May signal increased focus on subscription and tech-driven health services within the wellness sector.

U.S. consumer health and wellness stocks could see modest attention.

Limited to companies with similar subscription models worldwide.

Counterpoint

The new CEO's tech background may not translate to the weight‑loss market, risking execution delays.

Key entities

  • Stephen Bye

    Incoming President and CEO, former CEO of Ookla.

  • Weight Watchers (WW)

    Global leader in science‑backed weight management.

Related articles

$HRBHighAI 8/10

Firing on All Cylinders: H&R Block (NYSE:HRB) Q2 Earnings Lead the Way

H&R Block (HRB) reported Q2 revenue of $1.14B, up 3% YoY, beating estimates by 2.5%. The company raised full-year guidance, and its stock is up 9.2%. Frontdoor (FTDR) also beat expectations, while Matthews (MATW) and Pool (POOL) missed, with stocks down 23.7% and 6%, respectively. WeightWatchers (WW) reported a 14.2% revenue decline but beat EPS estimates, with stock up 15.2%.

$WWMedAI 8/10

WW (WW) Q2 2026 Earnings Call Transcript

WeightWatchers (WW) reported Q2 2026 revenue of $162.3 million, down 14.2% year over year, with behavioral revenue falling 22.7% to $121.5 million. Clinical end-of-period subscribers rose 55.7% to 197,000 and total subscribers fell to 2.5 million. Adjusted EBITDA was $39.8 million. 2026 guidance: revenue $620-$635 million, adjusted EBITDA $105-$115 million.

$WWMed

WW International Q2 Earnings Call Highlights

WW International (NASDAQ:WW) reported Q2 average revenue per user up 10.2% YoY. Clinical subscription revenue rose 30.4% to $39.9M, while behavioral fell 22.7% to $121.5M. Gross margin was 70.3% (adjusted 73.6%). WW ended with $101.5M cash, repaid debt, and reaffirmed 2026 revenue $620M-$635M and adjusted EBITDA $105M-$115M.

$WWMed

WeightWatchers’s (NASDAQ:WW) Q2 CY2026: Beats On Revenue

WeightWatchers (NASDAQ:WW) reported Q2 CY2026 revenue of $162.3 million, down 14.2% year on year, but 2% above Wall Street estimates, according to the company. Full-year revenue guidance is $627.5 million at the midpoint, 0.7% below analysts’ estimates. GAAP profit was $1.41 per share above consensus; shares fell 1.3% to $15.23 after the report.

$WWMed

WW INTERNATIONAL, INC. (WW): Results of Operations and Financial Condition

WW INTERNATIONAL, INC. (WW) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Weight Watchers Announces Second Quarter 2026 Results Total End of Period Subscribers of 2.5 million; End of Period Clinical Subscribers of 197 thousand, up 55.7% year-over-year Core+ End of Period Subscribers of 541 thousand, up 13.9% year-over-year, reflecting thir